date,title,source
Oct-22-18,Here's Why Kura Oncology Fell Today,Motley Fool
Oct-22-18,Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC,GlobeNewswire
Oct-23-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Dropbox, Kura Oncology, DHT, Wayfair, US Foods Holding, and InflaRx N.V  New Research Emphasizes Economic Growth",GlobeNewswire
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-29-18,Kura Oncology to Report Third Quarter 2018 Financial Results,GlobeNewswire
Nov-01-18,Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting,GlobeNewswire
Nov-05-18,Kura Oncology: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-05-18,Kura Oncology Initiates Registration-Directed Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinomas,GlobeNewswire
Nov-06-18,Kura Oncology to Participate in Two Upcoming Investor Conferences,GlobeNewswire
